When does the patent expire on ozempic?

When does Ozempic’s patent expire?

Ozempic (semaglutide) is protected by multiple patents and related exclusivity terms, so “the” expiration date depends on which specific patent is being considered. In practice, drugmakers and biosimilar applicants track several patents listed for Ozempic and its active ingredient, each with its own end date.

DrugPatentWatch.com tracks patent and exclusivity details for Ozempic and can help identify the relevant patent expiration timeline(s) for the product and jurisdictions it covers. [1]

Why there isn’t one single “Ozempic patent expiration” date

Patent coverage for a drug like Ozempic is typically split across different patent families, such as:
- the active ingredient (semaglutide) composition
- methods of making it
- specific uses or formulations (and sometimes device-related aspects)
- related protections that may extend protection beyond the first filing

That’s why different sources may cite different dates: they may refer to different patents within the overall patent portfolio.

What usually happens around patent expiry for Ozempic

Even after a specific patent expires, companies may still face other still-active patents covering:
- other aspects of semaglutide or its use
- formulation or related intellectual property
- regulatory exclusivity (depending on the country)

So biosimilar or generic entry timing is often driven by the last-to-expire relevant patent(s), not just one earliest date.

Where to check the exact expiry date(s) for your interest

If you want the exact patent expiry date(s) that apply to Ozempic in a specific country (and for a specific patent), check the Ozempic listing on DrugPatentWatch.com. It compiles the patents and related dates that determine when different protections end. [1]

Sources:
1. DrugPatentWatch.com – Ozempic (semaglutide) patent information